{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:38:20Z","timestamp":1774485500965,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.virusres.2012.03.006","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T21:05:00Z","timestamp":1331931900000},"page":"77-86","source":"Crossref","is-referenced-by-count":7,"title":["Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus"],"prefix":"10.1016","volume":"166","author":[{"given":"Reshma","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gajanan","family":"Sapkal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lata","family":"Mahishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratip","family":"Shil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind M.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2012.03.006_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0264-410X(99)00180-2","article-title":"Immunization with plasmid DNA encoding the envelope glycoprotein of Japanese Encephalitis virus confers significant protection against intracerebral viral challenge without inducing detectable antiviral antibodies","volume":"18","author":"Ashok","year":"1999","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0010","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1743-422X-8-382","article-title":"Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters","volume":"8","author":"Ahsan","year":"2011","journal-title":"Virol J."},{"issue":"4","key":"10.1016\/j.virusres.2012.03.006_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11262-009-0417-3","article-title":"Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB\/c mice","volume":"40","author":"Arashkia","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.virusres.2012.03.006_bib0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2334-11-64","article-title":"Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera","volume":"11","author":"Batra","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"13\u201314","key":"10.1016\/j.virusres.2012.03.006_bib0030","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.vaccine.2003.09.048","article-title":"Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens","volume":"22","author":"Bazhan","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0405","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2008.06.005","article-title":"Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates","volume":"80","author":"Bernardo","year":"2008","journal-title":"Antiviral. Res."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0035","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4269\/ajtmh.1985.34.1203","article-title":"Fatal outcome in Japanese encephalitis","volume":"34","author":"Burke","year":"1985","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"Pt 11","key":"10.1016\/j.virusres.2012.03.006_bib0040","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1099\/0022-1317-69-11-2741","article-title":"Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain","volume":"69","author":"Cecilia","year":"1988","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/dna.2006.0547","article-title":"Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein","volume":"6","author":"Chen","year":"2007","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.virusres.2012.03.006_bib0050","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.virusres.2012.03.006_bib0055","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1189\/jlb.1104627","article-title":"Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors","volume":"78","author":"Coban","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0065-2660(05)54011-2","article-title":"DNA vaccine","volume":"54","author":"Cui","year":"2005","journal-title":"Adv. Genet."},{"issue":"7","key":"10.1016\/j.virusres.2012.03.006_bib0065","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s007050170103","article-title":"Monoclonal antibody raised against envelope glycoprotein peptide neutralizes Japanese encephalitis virus","volume":"146","author":"Dewasthaly","year":"2001","journal-title":"Arch. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2174\/092986607780990028","article-title":"Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice","volume":"14","author":"Dewasthaly","year":"2007","journal-title":"Protein Pept. Lett."},{"issue":"4","key":"10.1016\/j.virusres.2012.03.006_bib0075","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/0008-5472.CAN-03-2196","article-title":"Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine","volume":"64","author":"Duraiswamy","year":"2004","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.virusres.2012.03.006_bib0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.virusres.2011.03.030","article-title":"Delineation of an epitope on domain I of Japanese encephalitis virus Envelope glycoprotein using monoclonal antibodies","volume":"158","author":"Gangwar","year":"2011","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.virusres.2011.08.008","article-title":"Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes","volume":"163","author":"Gangwar","year":"2012","journal-title":"Virus Res."},{"issue":"12","key":"10.1016\/j.virusres.2012.03.006_bib0090","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/eji.200324000","article-title":"Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene","volume":"33","author":"Ghochikyan","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"14","key":"10.1016\/j.virusres.2012.03.006_bib0095","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1128\/JVI.00291-08","article-title":"Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo","volume":"82","author":"Goncalvez","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0100","unstructured":"Gore, M.M., Kolaskar, A.S., Dewasthaly, S.S., Kulkarni-Kale, U.D., Sawant, S., 2008. Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus. Patent no.: US7 425,335 B2."},{"issue":"9","key":"10.1016\/j.virusres.2012.03.006_bib0105","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"Guirakhoo","year":"2004","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2012.03.006_bib0110","first-page":"141","article-title":"Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies","volume":"47","author":"Gupta","year":"2003","journal-title":"Acta Virol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1146\/annurev.immunol.18.1.927","article-title":"DNA vaccines: immunology application, and optimization","volume":"18","author":"Gurunathan","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0120","series-title":"Vaccine","first-page":"919","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2004"},{"key":"10.1016\/j.virusres.2012.03.006_bib0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev. Vaccines"},{"issue":"11","key":"10.1016\/j.virusres.2012.03.006_bib0130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/CVI.00145-07","article-title":"Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes","volume":"14","author":"Hapugoda","year":"2007","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.antiviral.2008.06.005","article-title":"Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates","volume":"80","author":"Hermida","year":"2008","journal-title":"Antiviral Res."},{"issue":"16","key":"10.1016\/j.virusres.2012.03.006_bib0140","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.vaccine.2006.01.036","article-title":"A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates","volume":"24","author":"Hermida","year":"2006","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.virusres.2012.03.006_bib0145","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2012.03.006_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/VAAT.S6105","article-title":"A critical appraisal of Ixiaro\u00ae\u2014a cell-derived inactivated vaccine for Japanese encephalitis","volume":"1","author":"Jones","year":"2009","journal-title":"Virus Adapt. Treat."},{"issue":"4","key":"10.1016\/j.virusres.2012.03.006_bib0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13550280390218454","article-title":"Development of a recombinant vaccine against Japanese encephalitis","volume":"9","author":"Kaur","year":"2003","journal-title":"J. Neurovirol."},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/338015","article-title":"Plasmid DNA immunization against Japanese encephalitis virus: immunogenicity of membrane-anchored and secretory envelope protein","volume":"185","author":"Kaur","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2012.03.006_bib0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nprot.2009.2","article-title":"Protein structure prediction on the web: a case study using the Phyre server","volume":"4","author":"Kelley","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virusres.2012.03.006_bib0165","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.141.10.3606","article-title":"Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies","volume":"141","author":"Kimura-Kuroda","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.virusres.2012.03.006_bib0175","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines","volume":"158","author":"Klinman.","year":"1997","journal-title":"J. Immunol."},{"issue":"23\u201324","key":"10.1016\/j.virusres.2012.03.006_bib0180","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/S0264-410X(02)00238-4","article-title":"Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine","volume":"20","author":"Kojima","year":"2002","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.virusres.2012.03.006_bib0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of Toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.virusres.2012.03.006_bib0200","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1128\/JVI.01850-08","article-title":"Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells","volume":"83","author":"Krishna","year":"2009","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0205","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1099\/vir.0.19531-0","volume":"85","author":"Kumar","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2012.03.006_bib0210","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1086\/381768","article-title":"Impaired T helper 1 function of nonstructural protein 3-specific T cells in Japanese patients with encephalitis with neurological sequelae","volume":"189","author":"Kumar","year":"2004","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0215","first-page":"417","article-title":"Analysis of computer-predicted antibody inducing epitope on Japanese encephalitis virus","volume":"37","author":"Kutubuddin","year":"1993","journal-title":"Acta Virol."},{"issue":"1\u20132","key":"10.1016\/j.virusres.2012.03.006_bib0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0161-5890(91)90098-5","article-title":"Recognition of helper T cell epitopes in envelope (E) glycoprotein of Japanese encephalitis, west Nile and Dengue viruses","volume":"28","author":"Kutubuddin","year":"1991","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.virusres.2012.03.006_bib0225","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.virusres.2012.03.006_bib0230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK\u2014a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.virusres.2012.03.006_bib0235","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.micinf.2008.12.004","article-title":"A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity","volume":"2","author":"Leng","year":"2009","journal-title":"Microbes Infect."},{"issue":"20","key":"10.1016\/j.virusres.2012.03.006_bib0240","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.vaccine.2011.03.002","article-title":"Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses","volume":"29","author":"Li","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2012.03.006_bib0245","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/intimm\/dxh305","article-title":"A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice","volume":"10","author":"Li","year":"2005","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0250","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0035-9203(02)90294-4","article-title":"Clinical and immunological risk factors for severe disease in Japanese encephalitis","volume":"96","author":"Libraty","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10529-007-9529-9","article-title":"Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus","volume":"30","author":"Lin","year":"2008","journal-title":"Biotechnol. Lett."},{"issue":"5","key":"10.1016\/j.virusres.2012.03.006_bib0260","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CVI.00405-09","article-title":"Identification of immunodominant B- and T-cell combined epitopes in outer membrane lipoproteins LipL32 and LipL21 of Leptospira interrogans","volume":"17","author":"Lin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.virusres.2012.03.006_bib0265","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2004","journal-title":"J. Immunol."},{"issue":"32","key":"10.1016\/j.virusres.2012.03.006_bib0270","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1016\/S0264-410X(01)00233-X","article-title":"Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines","volume":"19","author":"Livingston","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2012.03.006_bib0275","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0161-5890(92)90054-2","article-title":"T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions","volume":"10","author":"L\u00f6wenadler","year":"1992","journal-title":"Mol. Immunol."},{"issue":"20","key":"10.1016\/j.virusres.2012.03.006_bib0280","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.vaccine.2008.03.028","article-title":"Vector-based minigene vaccine approach results in strong induction of T-cell responses specific of hepatitis C virus","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virusres.2012.03.006_bib0285","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/092986609788681788","article-title":"Polytope DNA vaccine development against hepatitis C virus: a streamlined approach from in silico design to in vitro and primary in vivo analyses in BALB\/c mice","volume":"16","author":"Memarnejadian","year":"2009","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.virusres.2012.03.006_bib0290","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1743-422X-8-119","article-title":"Improving the potency of DNA vaccine against chicken anemia virus (CAV) by fusing VP1 protein of CAV to Marek's Disease Virus (MDV) type-1 VP22 protein","volume":"8","author":"Moeini","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2012.03.006_bib0300","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2180-10-212","article-title":"Frequent associations between CTL and T-helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs","volume":"10","author":"Paul","year":"2010","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.virusres.2012.03.006_bib0305","first-page":"10","article-title":"Molecular mechanisms of antibody-mediated neutralization of flavivirus infection","volume":"12","author":"Pierson","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"issue":"Pt 12","key":"10.1016\/j.virusres.2012.03.006_bib0310","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1099\/0022-1317-83-12-2973","article-title":"Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors","volume":"83","author":"Pontarollo","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2012.03.006_bib0315","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1172\/JCI38330","article-title":"Vaccinology in the genome era","volume":"119","author":"Rinaudo","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0320","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1128\/JVI.66.6.3385-3390.1992","article-title":"Enhancement 883 of the antibody response to flavivirus B-cell epitopes by using homologous or 884 heterologous T-cell epitopes","volume":"66","author":"Roehrig","year":"1992","journal-title":"J. Virol."},{"issue":"Pt 3","key":"10.1016\/j.virusres.2012.03.006_bib0325","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/vir.0.19525-0","article-title":"Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles","volume":"85","author":"Rueda","year":"2004","journal-title":"J. Gen. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2012.03.006_bib0330","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4269\/ajtmh.2007.77.1139","article-title":"Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection","volume":"77","author":"Sapkal","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"19","key":"10.1016\/j.virusres.2012.03.006_bib0335","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1021\/jp984217f","article-title":"The GROMOS biomolecular simulation program package","volume":"103","author":"Scott","year":"1999","journal-title":"J. Phys. Chem. A"},{"issue":"3\u20134","key":"10.1016\/j.virusres.2012.03.006_bib0340","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/biol.2001.0297","article-title":"The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation","volume":"29","author":"Sette","year":"2001","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/infdis\/173.1.24","article-title":"Use of an intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines","volume":"173","author":"Shirai","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14760584.1.2.207","article-title":"Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes","volume":"1","author":"Suhrbier","year":"2002","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.virusres.2012.03.006_bib0355","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1743-422X-7-363","article-title":"Protection against H1N1 influenza challenge by a DNA vaccine expressing H3\/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes","volume":"7","author":"Tan","year":"2010","journal-title":"Virol. J."},{"issue":"4","key":"10.1016\/j.virusres.2012.03.006_bib0360","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.160.4.1717","article-title":"Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination","volume":"160","author":"Thomson","year":"1998","journal-title":"J Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0365","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.157.2.822","article-title":"Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes","volume":"157","author":"Thomson","year":"1996","journal-title":"J. Immunol."},{"issue":"26","key":"10.1016\/j.virusres.2012.03.006_bib0370","doi-asserted-by":"crossref","first-page":"14660","DOI":"10.1073\/pnas.94.26.14660","article-title":"Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion","volume":"94","author":"Toes","year":"1997","journal-title":"Proc. Natl. Acad. Sci U.S.A.."},{"key":"10.1016\/j.virusres.2012.03.006_bib0375","series-title":"Groningen Molecular Simulation (GROMOS) Library Manual","author":"van Gunsteren","year":"1987"},{"issue":"9","key":"10.1016\/j.virusres.2012.03.006_bib0380","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.4049\/jimmunol.166.9.5366","article-title":"Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine","volume":"166","author":"Velders","year":"2001","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.virusres.2012.03.006_bib0385","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.vaccine.2005.11.042","article-title":"Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2012.03.006_bib0390","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2010.04.133","article-title":"Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB\/c mice","volume":"396","author":"Wei","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.virusres.2012.03.006_bib0395","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1743-422X-7-161","article-title":"The epitope of the VP1 protein of porcine parvovirus","volume":"2010","author":"Xie","year":"2010","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.virusres.2012.03.006_bib0400","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jmv.1890290211","article-title":"Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies","volume":"29","author":"Zhang","year":"1989","journal-title":"J. Med. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170212000986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170212000986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T06:11:21Z","timestamp":1687327881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170212000986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":80,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0168170212000986"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2012.03.006","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}